| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $2.0M | +0.9% |
| R&D Expense | $18.6M | +5.4% |
| SG&A Expense | $16.6M | -7.2% |
| Operating Income | -$34.3M | +0.4% |
| Interest Expense | $6.4M | -49.8% |
| Pre-tax Income | -$41.9M | +13.4% |
| Net Income | -$41.3M | +13.0% |
| EPS (Basic) | -$1.79 | +95.1% |
| EPS (Diluted) | -$1.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | +18.3% |
| Accounts Receivable | $2.0M | +4.7% |
| Inventory | $9.2M | +30.8% |
| Current Assets | $28.0M | +25.3% |
| Total Assets | $50.8M | +7.0% |
| Current Liabilities | $14.0M | -53.9% |
| Total Liabilities | $45.9M | -6.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.2M | -0.4% |
| Capital Expenditures | $77K | +0.0% |
| Investing Cash Flow | -$1.7M | +0.0% |
| Financing Cash Flow | $34.2M | +47.7% |
| Free Cash Flow | -$33.3M | -0.4% |
| +95.1% |
| Stockholders' Equity |
| $4.9M |
| +461.1% |